Mormil
Latest round
- Series A
Last raised
- Apr 2026
Total raised
- $2.6M
Investors
- 7
About Mormil
a. Mormil, engages in developing a drug discovery platform by observing the movement of molecules., Ltd. The company offers a core drug discovery technology platform that combines a chemical tongue with NMR (Nuclear Magnetic Resonance), a sensing technique that detects the movement and condition of molecules. As of April 2026, the company plans to expand drug discovery pipelines, advance molecular dynamics platforms, progress ALS and AVWS programs, initiate clinical trials, strengthen pharmaceutical partnerships for commercialization, and global expansion.
Who invested in Mormil
7 investors across 2 rounds
See all investors in Mormil
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Mormil
Who invested in Mormil?
Mormil has 7 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mormil raised?
Mormil has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Mormil last raise money?
Mormil's most recent round on record is a Series A, in Apr 2026.
What does Mormil do?
Mormil is a biotechnology company.
Where is Mormil headquartered?
Mormil is headquartered in Japan.
Which VCs invest in companies like Mormil?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Mormil's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mormil? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.